Company: MVIS
Filing Date: 2025-03-26
Form Type: 10-K
Source: 0001641172-25-000783
Chunk: 5

Company: MICROVISION, INC.
Filing Date: 2025-03-26
Form: 10-K
Item: Item 1A
Chunk 5
---
 stock to
so-called penny stock rules that impose additional sales practice and market-making requirements on broker-dealers who sell or make a
market in such securities. Consequently, removal from The Nasdaq Global Market and failure to obtain listing on another market or exchange
could affect the ability or willingness of broker-dealers to sell or make a market in our common stock and the ability of purchasers
of our common stock to sell their securities in the secondary market.

On
March 20, 2025, the closing price of our common stock was $1.36 per share.

Our
lack of significant financial resources may limit our revenues, potential profits, overall market share,
or value.

Our
products and solutions compete with other pureplay lidar developers, most of which have raised and exhausted significant capital in
their development and production efforts. We also face competition from OEMs and Tier 1 suppliers that have internally developed
lidar sensors. All of these OEMS and Tier 1s are significantly larger, more well-resourced, have long operating histories and enjoy
relevant brand recognition. With greater resources over the past several years, our pureplay lidar competitors have in the past
developed and commercialized products more quickly than us and may now have access to more entrenched sales channels. This
historical imbalance in financial resources and access could result for us in reduced revenues, lower margins or loss of market
share, any of which could reduce the value of our business. Additionally, for a variety of reasons, customers may choose to purchase
from suppliers that have substantially greater financial or other resources than we have.

Risks
Related to Fundraising Transactions and the Convertible Note

Our stockholders
will experience further dilution if we issue additional equity securities in future fundraising transactions.

We
are generally not restricted from issuing additional common stock, including any securities that are convertible into or exchangeable
for, or that represent the right to receive, common stock. If we issue additional common stock, or securities convertible into or exchangeable
or exercisable for common stock (including additional convertible notes to the holder of the convertible note issued by us in October
2024 pursuant to the securities purchase agreement dated October 14, 2024), our stockholders could experience additional dilution, and
any such issuances may result in downward pressure on the price of our common stock.

Sales
of shares of our common stock by the holder of the October 2024 convertible note may cause our stock price to decline.

Sales
of